From the paper[1]:
"Similar to CNR1, the cannabinoid receptor CNR2 was also found to be highly expressed and correlated with worse prognosis in tumors such as breast cancer (16), renal cancer (17), lung cancer (51), and HNSCC (21). In our study, the expression of CNR2 mRNA was upregulated in HNSCC compared with normal samples, and much higher in HPV-positive HNSCC samples. Meanwhile, knockdown of the expression of CNR2 inhibited the proliferation of HPV-positive HNSCC in vitro and in vivo. In addition, the selective CNR2 agonist Hu308 increased the growth, migration, and inhibited the apoptosis of HPV-positive HNSCC cells, whereas the selective CNR2 antagonist SR144528 exhibited an opposite effect. These phenomena were also observed in other tumors such as colon cancer, in which CNR2 activation promoted cancer progression via the AKT/GSK3β signaling pathway when cannabinoids used in concentrations similar to those in marijuana exposure (42)."
I hope someone with a background in this area can thoroughly evaluate this paper and explain to us laymen how reliable they think its methods and conclusions are. I also hope followup studies are done, particularly in humans, as this study was only carried out in cells and in mice.
As someone fighting cancer, this study worries me, despite the study being only done on cells and mice, and despite anti-drug research having a disgraceful history, which usually makes me take such studies with a grain of salt.
[1] - https://clincancerres.aacrjournals.org/content/26/11/2693